ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
67.722,52
0,00%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Zymeworks Inc (ZYME)

  7. Zymeworks Inc (ZYME) News

ZYME

Zymeworks (ZYME)

Zymeworks Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ZYME
DatumZeitQuelleÜberschriftSymbolFirma
28/05/202412h30GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
02/05/202422h05GlobeNewswire Inc.Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:ZYMEZymeworks Inc
30/04/202412h00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
11/04/202412h00GlobeNewswire Inc.Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:ZYMEZymeworks Inc
08/04/202412h00GlobeNewswire Inc.Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
28/03/202411h00GlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
27/03/202411h00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
07/03/202422h46Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZYMEZymeworks Inc
07/03/202422h36Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ZYMEZymeworks Inc
06/03/202423h25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ZYMEZymeworks Inc
06/03/202422h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
06/03/202422h09GlobeNewswire Inc.Zymeworks Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ZYMEZymeworks Inc
05/03/202422h30GlobeNewswire Inc.Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual MeetingNASDAQ:ZYMEZymeworks Inc
27/02/202412h00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
22/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
14/02/202412h00GlobeNewswire Inc.Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference CallNASDAQ:ZYMEZymeworks Inc
08/02/202422h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
08/02/202412h00GlobeNewswire Inc.Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of DirectorsNASDAQ:ZYMEZymeworks Inc
31/01/202412h00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
09/01/202400h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
06/01/202403h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
06/01/202403h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
05/01/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
04/01/202412h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
04/01/202412h15GlobeNewswire Inc.Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025NASDAQ:ZYMEZymeworks Inc
04/01/202412h00GlobeNewswire Inc.Zymeworks Announces Additional Leadership AppointmentsNASDAQ:ZYMEZymeworks Inc
03/01/202422h32Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ZYMEZymeworks Inc
26/12/202314h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
26/12/202314h00GlobeNewswire Inc.Zymeworks Announces $50 Million Private Placement to EcoR1 CapitalNASDAQ:ZYMEZymeworks Inc
15/12/202314h30GlobeNewswire Inc.Zymeworks Added to Nasdaq Biotechnology IndexNASDAQ:ZYMEZymeworks Inc
 Showing the most relevant articles for your search:NASDAQ:ZYME

Kürzlich von Ihnen besucht

BIT
UB8J2C
Unicredit Bank
BIT
P17XM4
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten